Brainsway (BWAY)
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep T...
- Open
- 15.160
- High
- 15.326
- Low
- 14.845
- Prev. Close
- 15.170
- Volume
- 35.57K
- Turnover
- 535.14K
- Avg Price
- 15.044
- Bid/Ask Ratio
- -81.82%
- Amplitude
- 3.17%
- 52wk High
- 17.400
- Volume Ratio
- 0.24
- Turnover Ratio
- 0.29%
Brainsway Analyst Rating
View moreForecast & Rating
Aug 13, 2026Price forecast
$18.6024.66%
Forecast & RatingStrong buy
3analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Market Beat · Aug 13 at 01:48 PM
Brainsway (NASDAQ:BWAY) Stock Price Expected to Rise, LADENBURG THALM/SH SH Analyst Says
- Quartr · Aug 13 at 04:40 AM
BWAY: Q2 2026 delivered 35% revenue growth, margin expansion, and raised full-year guidance
- Market Beat · Aug 13 at 04:02 AM
Brainsway Q2 Earnings Call Highlights
- Market Beat · Aug 12 at 02:20 PM
Brainsway (NASDAQ:BWAY) Stock Price Up 13% on Analyst Upgrade
- benzinga_article · Aug 12 at 01:51 PM
BrainsWay shares are trading higher after the company reported better-than-expected Q2 sales results and raised its FY26 sales guidance above analyst estimates.
- Quartr · Aug 12 at 06:38 AM
BWAY: Q2 2026 revenue up 35% YoY, margins and guidance raised, with strong cash flow and system growth
